BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30830539)

  • 1. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems.
    Gan T; Huang B; Chen Q; Sinner HF; Lee CY; Sloan DA; Randle RW
    Ann Surg Oncol; 2019 Sep; 26(9):2703-2710. PubMed ID: 30830539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?
    Manzardo OA; Cellini M; Indirli R; Dolci A; Colombo P; Carrone F; Lavezzi E; Mantovani G; Mazziotti G; Arosio M; Lania AGA
    Endocr Relat Cancer; 2020 Jun; 27(6):325-336. PubMed ID: 32229701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
    Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
    Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
    Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
    Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
    Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.
    Kim K; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Ther Adv Endocrinol Metab; 2020; 11():2042018820921019. PubMed ID: 32489582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
    Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on Cancer staging systems.
    Elbasan O; Gogas Yavuz D
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):261-273. PubMed ID: 36756784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
    Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
    Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.